...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Molecular and functional characteristics of ??3- adrenoceptors in late pregnant mouse uterus: A comparison with ??2-adrenoceptors
【24h】

Molecular and functional characteristics of ??3- adrenoceptors in late pregnant mouse uterus: A comparison with ??2-adrenoceptors

机译:晚期妊娠小鼠子宫中β3-肾上腺素受体的分子和功能特性:与β2-肾上腺素受体的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

??3-adrenoceptor is a potential target for uterine relaxant drugs for the treatment of preterm labor. Mouse is an ideal experimental model for preterm labor. However, there is limited information on the molecular and functional characteristics of ??3-adrenoceptors in mouse uterus. Therefore, the current study was undertaken to characterize the ??3-adrenoceptors in late pregnant mouse uterus by molecular and functional experiments and to compare their expression and function with the ??2-adrenoceptors. Using RT-PCR, we demonstrated the presence of ??3-adrenoceptor mRNA in the mouse uterus. Accordingly, selective ??3-adrenoceptor agonist SAR150640 (ethyl-4-{trans-4-[((2S)-2- hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl)amino]cyclohexyl} benzoate hydrochloride) caused concentration-dependent relaxation of the isolated tissue. SR59230A (1 ??M), a selective antagonist of ??3-adrenoceptors, antagonized the relaxant response to SAR150640. Using real-time PCR we found that in comparison to ??3-adrenoceptor mRNA, ??2-adrenoceptor mRNA is predominantly expressed in the late pregnant mouse uterus. We then assessed the comparative efficiency of different ??-adrenoceptor agonists, such as SAR150640, salbutamol and isoprenaline to relax the tissue. SAR150640 (pD 2 6.64??0.21, Emax 104.9??7.95), salbutamol (pD2 8.57??0.062, Emax 103.1??3.22) and isoprenaline (pD2 9.48??0.084, Emax 102.9??5.18) caused concentration-dependent inhibition of uterine rhythmic contractions. While the maximal relaxation to these agonists was comparable, the order of potency was isoprenalinesalbutamolSAR. These results suggest that ??3-adrenoceptor mRNA is present in the pregnant mouse uterus and is functionally active. The predominance of ??2- over ??3-adrenoceptor expression may explain variable potency amongst the ??-adrenoceptor agonists. ? 2012 Elsevier B.V.
机译:3-β肾上腺素受体是子宫松弛药治疗早产的潜在靶标。鼠标是早产的理想实验模型。但是,关于小鼠子宫内β3-肾上腺素受体的分子和功能特性的信息有限。因此,目前进行的研究是通过分子和功能实验表征晚期妊娠小鼠子宫中的β3-肾上腺素受体,并将它们的表达和功能与β2-肾上腺素受体相比较。使用RT-PCR,我们证明了小鼠子宫中存在β3-肾上腺素受体mRNA。因此,选择性的β3-肾上腺素受体激动剂SAR150640(乙基-4- {反式-4-[(((2S)-2-)-3-羟基-3- {4-羟基-3 [(甲基磺酰基)氨基]苯氧基}丙基)氨基[环己基}苯甲酸酯盐酸盐)引起离体组织的浓度依赖性松弛。 SR59230A(1μM)是β3-肾上腺素能受体的选择性拮抗剂,拮抗对SAR150640的松弛反应。使用实时PCR,我们发现,与β3-肾上腺素受体mRNA相比,β2-肾上腺素受体mRNA主要在晚期妊娠小鼠子宫中表达。然后,我们评估了不同的β-肾上腺素受体激动剂如SAR150640,沙丁胺醇和异丙肾上腺素使组织松弛的比较效率。 SAR150640(pD 26.64Δ0.21,Emax104.9Δ7.95),沙丁胺醇(pD28.57Δ0.062,Emax103.1Δ3.22)和异丙肾上腺素(pD29.48Δ0.084,Emax102.9Δ5.18)引起浓度依赖性抑制子宫节律性收缩。尽管这些激动剂的最大舒张程度是可比的,但效力的顺序为异丙肾上腺素>沙丁胺醇> SAR。这些结果表明,β3-肾上腺素受体mRNA存在于怀孕的小鼠子宫中并且具有功能活性。 ?? 2-比?? 3-肾上腺素受体表达的优势可能解释了??-肾上腺素受体激动剂的可变效力。 ? 2012年Elsevier B.V.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号